Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Cell Rep. 2022 Aug 16;40(7):111234. doi: 10.1016/j.celrep.2022.111234.
Spermidine is essential for cellular growth and acts as a prerequisite of hypusination, a post-translational modification of eukaryotic initiation factor 5A (eIF5A), allowing the translation of polyproline-containing proteins. Here, we show that oncogenic Kaposi's sarcoma-associated herpesvirus (KSHV) increases spermidine synthesis and eIF5A hypusination to enhance expression of polyproline-containing latency-associated nuclear antigen (LANA) for viral episomal maintenance. KSHV upregulates intracellular spermidine levels by dysregulating polyamine metabolic pathways in three-dimensional (3D) culture and 2D de novo infection conditions. Increased intracellular spermidine leads to increased eIF5A hypusination, ultimately enhancing LANA expression. In contrast, inhibition of spermidine synthesis or eIF5A hypusination alleviates LANA expression, decreasing viral episomal maintenance and KSHV-infected cell proliferation in vitro and in vivo, which is reversed by spermidine supplement. This demonstrates that KSHV hijacks spermidine synthesis and eIF5A hypusination pathways to enhance LANA expression for viral episomal maintenance, suggesting polyamine metabolism and eIF5A hypusination as therapeutic targets for KSHV-induced tumorigenesis.
精胺是细胞生长所必需的,并且是真核起始因子 5A (eIF5A) 的翻译后修饰hypusination 的前提条件,允许多脯氨酸蛋白的翻译。在这里,我们表明致癌的卡波济肉瘤相关疱疹病毒 (KSHV) 通过扰乱三维 (3D) 培养和 2D 从头感染条件下的多胺代谢途径来增加精胺合成和 eIF5A hypusination,以增强含多脯氨酸的潜伏相关核抗原 (LANA) 的表达,从而维持病毒的游离体。KSHV 通过在三维(3D)培养和 2D 从头感染条件下扰乱多胺代谢途径来上调细胞内精胺水平。增加的细胞内精胺导致 eIF5A hypusination 增加,最终增强 LANA 表达。相比之下,抑制精胺合成或 eIF5A hypusination 可减轻 LANA 表达,减少病毒游离体的维持和 KSHV 感染细胞的增殖在体内和体内,通过补充精胺可逆转这种情况。这表明 KSHV 劫持精胺合成和 eIF5A hypusination 途径来增强 LANA 表达以维持病毒游离体,表明多胺代谢和 eIF5A hypusination 可作为 KSHV 诱导的肿瘤发生的治疗靶点。